A VLADUTIU
Overview
Explore the profile of A VLADUTIU including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maruyama S, Cantu 3rd E, DEMARTINO C, VLADUTIU A, CALDWELL P, Wang C, et al.
J Am Soc Nephrol
. 1999 Oct;
10(10):2102-8.
PMID: 10505686
In the course of studies on the humoral consequences of swine to primate xenotransplantation, the investigators induced formation of glomerular subepithelial immune deposits and tubular lesions in pigs injected with...
2.
Luft K, VLADUTIU A
Arch Pathol Lab Med
. 1999 Sep;
123(6):461-2.
PMID: 10490426
No abstract available.
3.
Magistrelli C, Samoilova E, Agarwal R, Banki K, Ferrante P, VLADUTIU A, et al.
Immunogenetics
. 1999 Aug;
49(10):829-34.
PMID: 10436175
Antinuclear autoantibodies are a hallmark of systemic lupus erythematosus (SLE). Autoantibodies to HRES-1/p28, a 28 000 M(r) nuclear protein, commonly occur in patients with SLE. HRES-1 is a single-copy endogenous...
4.
Natelson B, LaManca J, Denny T, VLADUTIU A, Oleske J, Hill N, et al.
Am J Med
. 1998 Oct;
105(3A):43S-49S.
PMID: 9790481
The purpose of this study was to evaluate the immune dysfunction hypothesis of chronic fatigue syndrome (CFS) by comparing immunologic data from patients with CFS with data from patients with...
5.
Anthone S, AMBRUS C, Kohli R, Min I, Anthone R, Stadler A, et al.
J Am Soc Nephrol
. 1995 Oct;
6(4):1271-7.
PMID: 8589296
Intravenous desferrioxamine (DFO) is the method commonly used to treat aluminum toxicity. This laboratory has developed a hollow fiber device with immobilized DFO, an "Aluminum DFO-HP" (DFO-HP), for the purpose...
6.
7.
Stadler I, Chadha K, Nakeeb S, Toumbis C, BUTSCH J, Mathur N, et al.
J Pharmacol Exp Ther
. 1994 Jan;
268(1):10-3.
PMID: 8301544
C57/BL/6 mice infected with LP-BM5 MuLV virus developed an AIDS-like disease (MAIDS) with splenomegaly, leukopenia, thrombocytopenia, anemia, decreased numbers of helper/inducer and suppressor/cytotoxic T-cells and decreased production of interferon alpha....
8.
Cavalot F, Miyata M, VLADUTIU A, Terranova V, DUBISKI S, Burlingame R, et al.
Am J Pathol
. 1992 Mar;
140(3):581-600.
PMID: 1546743
Immunization of rabbits with physicochemically altered homologous or even autologous IgG induces formation of antibodies combining with IgG of rabbit and of foreign species. Cardiac but not renal lesions were...
9.
Chen C, Nadal D, Cohen S, SCHLAPFER E, Mookerjee B, VLADUTIU A, et al.
Int Arch Allergy Immunol
. 1992 Jan;
97(4):295-300.
PMID: 1534551
One of the major problems using man-mouse chimeras is still the difficulty to demonstrate unequivocally engraftment of human cells in murine tissues. Using supravital labelling of human leukocytes with the...
10.
Noble B, Steward M, VLADUTIU A, Brentjens J
Clin Exp Immunol
. 1987 Feb;
67(2):277-82.
PMID: 2955967
Chronic serum sickness glomerulonephritis, induced in hyperimmunized rats by daily intravenous administration of bovine serum albumin, occurs in three stages, mild, moderate and severe, with abrupt onsets and distinctive features...